戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              ABPM 24-hr systolic blood pressure (SBP) (133.9+/-14.3 v
2                                              ABPM captured worsening of orthostatic tolerance postexe
3                                              ABPM data from reflex syncope patients and controls, mat
4                                              ABPM has allowed detailed assessment of circadian blood
5                                              ABPM with an autonomic diary is a widely accessible scre
6 d from 5.4% (0% ABPM; 5.4% HBPM) to 4.3% (0% ABPM; 4.3% HBPM) during the corresponding period (P = .9
7 f-office BP monitoring changed from 5.4% (0% ABPM; 5.4% HBPM) to 4.3% (0% ABPM; 4.3% HBPM) during the
8 office BP monitoring increased from 0.6% (0% ABPM; 0.6% HBPM) to 5.7% (3.7% ABPM; 2.0% HBPM) between
9 from 0.6% (0% ABPM; 0.6% HBPM) to 5.7% (3.7% ABPM; 2.0% HBPM) between the preimplementation and posti
10                 The immunopathology of ABPA, ABPM, and SAFS is incompletely understood.
11 omodulating therapies in patients with ABPA, ABPM, and SAFS requires additional larger studies.
12 ntation strategy consisting of an accessible ABPM service; electronic health record (EHR) tools to fa
13 sed event rates occurred in diabetes for all ABPM parameters for CV death and all-cause death.
14 ly associated with greater elevations in all ABPM indexes except for nighttime systolic indexed BP, a
15 d (2) HMWr was inversely associated with all ABPM indexes.
16 tervals can be accurately estimated using an ABPM.
17                  Twenty participants wore an ABPM for three hours and a data logger which synchronous
18 estigated the association between clinic and ABPM with an established biomarker of atherosclerosis (i
19                                     HBPM and ABPM were close according to Pearson bivariate correlati
20  the number of the combined cases of NTM and ABPM will increase with the increase in NTM; however, re
21 ent method for the combined cases of NTM and ABPM.
22                             Within-visit and ABPM variability in SBP were also lower in the amlodipin
23                                        Awake ABPM and nurse-determined BP measurements were lower tha
24         Twenty-four were hypertensive (awake ABPM>135/85 mm Hg and clinic/RN BP>140/90 mm Hg) before
25 , normotensive donors had no change in awake ABPM pressure (pre 121 +/- 1/75 +/- 2 vs. post 120 +/- 1
26 oportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg).
27   Seated, standing, and 24-h ambulatory BPs (ABPM) were obtained in adults without known cardiovascul
28 ction between blood pressure (as assessed by ABPM) and the heart, interest is growing in the applicat
29 nts (24%) were classified as hypertensive by ABPM criteria and 29 (17%) by clinic blood pressure (BP)
30 inclusion criteria as blacks and showing, by ABPM, daytime mean arterial pressure (MAP) in the same r
31                        This review describes ABPM and HBPM procedures, the blood pressure phenotypic
32                             SBP drops during ABPM are more common in reflex syncope patients than in
33 the development of Th2 responses seen during ABPM.
34 sefulness of biologics like benralizumab for ABPM has been reported, but evidence to support their us
35 is study expands the current indications for ABPM to patients with reflex syncope.
36              BP variables were obtained from ABPM.
37 tment, there was a reduction in average 24-h ABPM by 14/7 mm Hg (systolic: 150 +/- 16 mm Hg vs. 136 +
38 60/100 mm Hg and diagnosis confirmed by 24-h ABPM of >/=130/80 mm Hg) who underwent catheter-based RD
39 urements over multiple days followed by 24-h ABPM.
40 and 12 asymptomatic TTR variant carriers had ABPM including autonomic diary and quantitative autonomi
41          Two hundred twenty-one patients had ABPM, and 142 patients had echocardiographic results ava
42 also measured the relationship between HBPM, ABPM, and organ damage as measured by albuminuria and le
43                       Lower baseline 24-hour ABPM measurements, as well as low SBP during follow-up,
44  as assessed by clinic, daytime, and 24-hour ABPM.
45                                     However, ABPM has important uses in assessing blood pressure as w
46 ght-to-total adiponectin ratio (HMWr), 24-hr ABPM, and dual x-ray absorptiometry measures of fat mass
47               Measurement variability (SD in ABPM) and the effects of misclassification were greatest
48 bulatory 24-hour blood pressure measurement (ABPM) as a screening tool for neurogenic orthostatic hyp
49  using an ambulatory blood pressure monitor (ABPM) with single lead ECG.
50  conducted 24-hour ambulatory BP monitoring (ABPM) and 17 969 participants in the 2011-2016 National
51 inamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by
52 etes and recommend ambulatory BP monitoring (ABPM) to diagnose and classify hypertension.
53  confirmed by 24-h ambulatory BP monitoring (ABPM).
54 graphy and 24-hour ambulatory BP monitoring (ABPM).
55 BP) on ambulatory blood pressure monitoring (ABPM) 157 +/- 22 mm Hg, despite medication with 5.4 +/-
56 linic: ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM).
57 rgoing ambulatory blood pressure monitoring (ABPM) and the number of publications using this techniqu
58 nce of ambulatory blood pressure monitoring (ABPM) for risk stratification in renal transplant patien
59 M with ambulatory blood pressure monitoring (ABPM) for the diagnosis of uncontrolled hypertension in
60        Ambulatory blood pressure monitoring (ABPM) has emerged as a valuable clinical and research to
61 in and ambulatory blood pressure monitoring (ABPM) in 33 pediatric renal transplant recipients (TXP),
62 ia for ambulatory blood pressure monitoring (ABPM) in patients with suspected reflex syncope are lack
63 ure by ambulatory blood pressure monitoring (ABPM) in treated hypertensive blacks and whites whose da
64        Ambulatory blood pressure monitoring (ABPM) is the preferred method to characterize blood pres
65 4-hour ambulatory blood pressure monitoring (ABPM) or HBPM combined with additional support or team-b
66 formed ambulatory blood pressure monitoring (ABPM) to assess the efficacy of the procedure.
67 4-hour ambulatory blood pressure monitoring (ABPM) was acquired.
68 , 24-h ambulatory blood-pressure monitoring (ABPM) was also studied.
69  24-hr ambulatory blood pressure monitoring (ABPM) were obtained.
70 years, ambulatory blood pressure monitoring (ABPM), facilitated by user-friendly instrumentation, has
71 4-hour ambulatory blood pressure monitoring (ABPM), pre-ejection period (PEP), and flow-mediated dila
72 n 24 h ambulatory blood-pressure monitoring (ABPM).
73 ], and ambulatory blood pressure monitoring [ABPM]), clinical, and renal characteristics (iothalamate
74           Allergic bronchopulmonary mycosis (ABPM) is a hypersensitivity lung disease in which fungal
75 n who had allergic bronchopulmonary mycosis (ABPM) with nontuberculous mycobacteriosis (NTM) was trea
76 istics of allergic bronchopulmonary mycosis (ABPM).
77 n form of allergic bronchopulmonary mycosis (ABPM); other fungi, including Candida, Penicillium, and
78 arriers and 20/26 (77%) patients with normal ABPM had abnormal AFT.
79 t, interest is growing in the application of ABPM to the practice of nephrology.
80 r discusses some of the technical aspects of ABPM, followed by a review of five areas of clinical res
81 to withhold or alter therapy on the basis of ABPM readings is testimony to its clinical value in the
82                       The characteristics of ABPM include severe asthma, eosinophilia, markedly incre
83 ing on 7 consecutive days, within 15 days of ABPM.
84              We also compared development of ABPM in young and mature mice and did not find any diffe
85 chronic inflammation, and the development of ABPM pathology in C. neoformans-infected lungs.
86                      Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warra
87 barriers to the successful implementation of ABPM and HBPM in clinical practice, proposes core compet
88                       Using a mouse model of ABPM caused by Cryptococcus neoformans infection of C57B
89                   Sensitivity/specificity of ABPM in detecting nOH and postprandial hypotension were
90 ng blood pressure, as well as the utility of ABPM in several situations.
91 AHA and the 2023 ESH HTN guidelines based on ABPM.
92 efined as a reduction of mean systolic BP on ABPM by 10 mm Hg or more at 6 months after RDN.
93    Six months after RDN, mean systolic BP on ABPM was significantly reduced from 157 +/- 22 mm Hg to
94 ce of systolic blood pressure (SBP) drops on ABPM.
95 01), independent of mean SBP in clinic or on ABPM.
96  of renal denervation or a sham procedure on ABPM measurements 6 months post-randomization.
97                               Variability on ABPM was a weaker predictor, but all measures of variabi
98 olic BP either at HBPM (R=0.42; P=0.0002) or ABPM (R=0.25; P=0.03).
99 ft ventricular mass and BP either at HBPM or ABPM.
100 pressure was the primary outcome, with other ABPM end points exploratory, and PEP and FMD were coseco
101  hypertension in kidney transplants requires ABPM.
102 dy-state" fungal infection and the resultant ABPM pathology.
103 ation with LVH supports the case for routine ABPM and cardiac structure evaluation as the standard of
104 lysis assessed outcome data from the Spanish ABPM Registry in 59 124 patients with complete available
105                            Evidence supports ABPM as the reference standard for confirming elevated o
106                                       In the ABPM substudy, reduced variability in daytime SBP in the
107 lack of reimbursement for performance of the ABPM procedure, the growth in its usage and the willingn
108 lementation strategy that included access to ABPM modestly increased out-of-office BP monitoring amon
109           In patients (n = 36) who underwent ABPM 6 months after treatment, there was a reduction in
110 black patients in our programs who underwent ABPM and met the above criteria were included in this st
111 l guidelines for strict BP control and using ABPM for classification and assessment of risk and contr
112 iew of five areas of clinical research using ABPM, and which are relevant to renal medicine: microalb
113 he clinical setting, pediatric studies using ABPM to evaluate elevated blood pressure have shown that
114             Controversy exists about whether ABPM or HBPM is superior for estimating risk for cardiov
115 re in kidney transplants when evaluated with ABPM mainly as a result of increased sleep systolic BP.
116 these have not been studied in patients with ABPM and SAFS.
117 utrition Examination Survey (NHANES) without ABPM.

 
Page Top